We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Association of Nirmatrelvir/Ritonavir Treatment and COVID-19-Neutralizing Antibody Titers in a Longitudinal Health Care Worker Cohort.
- Authors
Decker, Slade; Xiao, Shaoming; Dillen, Carly; Schumacher, Christina M; Milstone, Aaron M; Frieman, Matthew; Debes, Amanda K
- Abstract
Nirmatrelvir/ritonavir (NMV/r) is used for the treatment of coronavirus disease 2019 (COVID-19) infection. However, rebound COVID-19 infections can occur after taking NMV/r. We examined neutralizing antibodies to the severe acute respiratory syndrome coronavirus 2 spike protein before and after infection in people who did and did not take NMV/r to determine if NMV/r impedes the humoral immune response.
- Subjects
SARS-CoV-2; ANTIBODY titer; CORONAVIRUS disease treatment; CORONAVIRUS spike protein; COVID-19
- Publication
Open Forum Infectious Diseases, 2024, Vol 11, Issue 2, p1
- ISSN
2328-8957
- Publication type
Article
- DOI
10.1093/ofid/ofad625